Literature DB >> 21052660

Monitoring response to imatinib using MRI signals in aggressive fibromatosis.

Alexander Walter Sauter, Joerg T Hartmann, Marius S Horger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052660     DOI: 10.1007/s00259-010-1651-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

Review 1.  Pre-clinical PET/MR: technological advances and new perspectives in biomedical research.

Authors:  Hans F Wehrl; Martin S Judenhofer; Stefan Wiehr; Bernd J Pichler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

2.  Aggressive fibromatosis: MRI features with pathologic correlation.

Authors:  Justin C Lee; J Meirion Thomas; Simon Phillips; Cyril Fisher; Eleanor Moskovic
Journal:  AJR Am J Roentgenol       Date:  2006-01       Impact factor: 3.959

3.  Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib.

Authors:  Bernd Kasper; Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss; Peter Hohenberger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-19       Impact factor: 9.236

4.  Can the MRI signal of aggressive fibromatosis be used to predict its behavior?

Authors:  G Castellazzi; D Vanel; A Le Cesne; C Le Pechoux; H Caillet; F Perona; S Bonvalot
Journal:  Eur J Radiol       Date:  2008-11-28       Impact factor: 3.528

Review 5.  Multimodality imaging: beyond PET/CT and SPECT/CT.

Authors:  Simon R Cherry
Journal:  Semin Nucl Med       Date:  2009-09       Impact factor: 4.446

  5 in total
  2 in total

1.  Desmoid tumor of the anterior abdominal wall in female patients: comparison with endometriosis.

Authors:  H Krentel; G Tchartchian; R L De Wilde
Journal:  Case Rep Med       Date:  2012-06-12

2.  Imaging features of superficial and deep fibromatoses in the adult population.

Authors:  Eric A Walker; Jonelle M Petscavage; Pamela L Brian; Chika Iloanusi Logie; Kenneth M Montini; Mark D Murphey
Journal:  Sarcoma       Date:  2012-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.